Your browser doesn't support javascript.
loading
Four distinct trajectories of tau deposition identified in Alzheimer's disease.
Vogel, Jacob W; Young, Alexandra L; Oxtoby, Neil P; Smith, Ruben; Ossenkoppele, Rik; Strandberg, Olof T; La Joie, Renaud; Aksman, Leon M; Grothe, Michel J; Iturria-Medina, Yasser; Pontecorvo, Michael J; Devous, Michael D; Rabinovici, Gil D; Alexander, Daniel C; Lyoo, Chul Hyoung; Evans, Alan C; Hansson, Oskar.
  • Vogel JW; Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada. jacob.vogel@mail.mcgill.ca.
  • Young AL; Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Oxtoby NP; Centre for Medical Image Computing, University College London, London, UK.
  • Smith R; Department of Computer Science, University College London, London, UK.
  • Ossenkoppele R; Clinical Memory Research Unit, Lund University, Lund, Sweden.
  • Strandberg OT; Department of Neurology, Skåne University Hospital, Lund, Sweden.
  • La Joie R; Clinical Memory Research Unit, Lund University, Lund, Sweden.
  • Aksman LM; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands.
  • Grothe MJ; Clinical Memory Research Unit, Lund University, Lund, Sweden.
  • Iturria-Medina Y; Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
  • Pontecorvo MJ; Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
  • Devous MD; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Rabinovici GD; Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/Consejo Superior de Investigaciones Científicas/Universidad de Sevilla, Seville, Spain.
  • Alexander DC; Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada.
  • Evans AC; AVID Radiopharmaceuticals, Philadelphia, PA, USA.
  • Hansson O; AVID Radiopharmaceuticals, Philadelphia, PA, USA.
Nat Med ; 27(5): 871-881, 2021 05.
Article en En | MEDLINE | ID: mdl-33927414
ABSTRACT
Alzheimer's disease (AD) is characterized by the spread of tau pathology throughout the cerebral cortex. This spreading pattern was thought to be fairly consistent across individuals, although recent work has demonstrated substantial variability in the population with AD. Using tau-positron emission tomography scans from 1,612 individuals, we identified 4 distinct spatiotemporal trajectories of tau pathology, ranging in prevalence from 18 to 33%. We replicated previously described limbic-predominant and medial temporal lobe-sparing patterns, while also discovering posterior and lateral temporal patterns resembling atypical clinical variants of AD. These 'subtypes' were stable during longitudinal follow-up and were replicated in a separate sample using a different radiotracer. The subtypes presented with distinct demographic and cognitive profiles and differing longitudinal outcomes. Additionally, network diffusion models implied that pathology originates and spreads through distinct corticolimbic networks in the different subtypes. Together, our results suggest that variation in tau pathology is common and systematic, perhaps warranting a re-examination of the notion of 'typical AD' and a revisiting of tau pathological staging.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Corteza Cerebral / Proteínas tau / Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Corteza Cerebral / Proteínas tau / Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article